Skip to main content

Mohan Raju's Form 4 filing

Ventyx Biosciences, Inc. (VTYX) · filed Sep 7, 2023

Accession no.
0001209191-23-048620
Filed
Sep 7, 2023
Trade date
Sep 5, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $978.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mohan RajuCIK 0001878125Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 5, 2023Common StockMOption exerciseAcquired+30,000$8.04+$241,2001,542,911Direct
Sep 5, 2023Common StockSSaleDisposed−20,630$32.25F2−$665,317.51,522,281Direct
Sep 5, 2023Common StockSSaleDisposed−9,015$33.39F3−$301,010.851,513,266Direct
Sep 5, 2023Common StockSSaleDisposed−355$33.98F4−$12,062.91,512,911Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 5, 2023Common StockMOption exerciseDisposed−30,000$0.00$0365,286Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average share price of an aggregate total of 20,630 shares sold in the price range of $31.95 to $32.9422. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average share price of an aggregate total of 9,015 shares sold in the price range of $32.9524 to $33.90. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average share price of an aggregate total of 355 shares sold in the price range of $33.96 to $34.0802. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)